Submit Deal

FRONTIER MEDICINES

Summary

Frontier Medicines is a precision medicine company seeking to unlock the proteome to advance transformational therapies against otherwise undruggable disease-causing targets.

Deals Overview

Total Deals2

Valued Deals2

Total Value£ 128 M

Avg. Deal Size£ 64 M

Market Context

Senior Management

Chris Varma
Chairman and CEO

Sort

frontier medicines

HQ - United States

Pharmaceuticals

19 Jul 2021

Investment Date

£ 64 M

Deal Value

frontier medicines

HQ - United States

Pharmaceuticals

22 Feb 2024

Investment Date

£ 63 M

Deal Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy